Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation

SIMPLE SUMMARY: Hepatocellular Carcinoma (HCC) is one of the most common malignancies in the world with increasing prevalence. This review addresses the current and growing body of literature on the use of immune checkpoint inhibitors in patients with advanced HCC prior to liver transplantation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Katariya, Nitin N., Lizaola-Mayo, Blanca C., Chascsa, David M., Giorgakis, Emmanouil, Aqel, Bashar A., Moss, Adyr A., Uson Junior, Pedro Luiz Serrano, Borad, Mitesh J., Mathur, Amit K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101696/
https://www.ncbi.nlm.nih.gov/pubmed/35565184
http://dx.doi.org/10.3390/cancers14092056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101696/
https://www.ncbi.nlm.nih.gov/pubmed/35565184
http://dx.doi.org/10.3390/cancers14092056

Ejemplares similares